Clinical trial
Improving Management of Patients at High Risk for Osteoporotic Fractures…
NCT00139438 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00139438 |
|---|---|
| Title | Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038) |
| Official title | Improving Management of Patients at High Risk for Osteoporotic Fractures |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Behavioral |
| Interventions | Disease Management Assessment |
| Enrollment | 4,266 |
| Start date | Sep 1, 2004 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Aug 31, 2005 |
| Last update posted | Apr 22, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: